On August 22, U.S. West Coast Time, Xiang Zhenfei, Chairman and President of IntelliMicro, Prof. Yu-chong Tai of California Institute of Technology (Member of the U.S. National Academy of Engineering, Member of the American Institute for Medical and Biological Engineering, Founder and Former Chairman of Department of Medical Engineering of California Institute of Technology), and Yao Yangyi, President Assistant, visited Mr. Omar Ishrak, Former Chairman (current Board Member) of Intel and Former Chairman and CEO of Medtronic and Member of the Board of Trustees of California Institute of Technology, at his home. Omar Ishrak is a global leading figure in the high-tech and high-end medical industry. During his tenure, he successfully led the innovation transformation of Medtronic with clinical value as the core, driving its global strategic expansion and technological integration, with profound impacts on the industry. Prof. Mark Humayun of the University of Southern California, the Co-Founder, Broad Member, and Chief Medical Technology Office of IntelliMicro (Member of the U.S. National Academy of Engineering and Member of the U.S. National Academy of Medicine) was unable to attend the scene for guiding important surgeries, so he participated in the meeting through the network.
During the meeting, Chairman Xiang Zhenfei systematically introduced the core technology and project progress of IntelliMicro in the field of semiconductor technology and high-end medical devices, and elaborated on the Company’s R&D layout and industrialization path in cutting-edge areas such as neuromodulation and brain-computer interface. Omar Ishrak highly recognized IntelliMicro’s advanced technology, forward-looking layout and localization capability in the Chinese market, and shared the evolution trend of global medical technology and new models of international cooperation.
During the period, the two sides had an in-depth conversation, and shared the expectation that relying on IntelliMicro’s innovation platform and local policy resources, combining the advanced technology, global network and clinical experience in related fields of global high-tech and high-end medical companies such as Intel and Medtronic, carrying out innovative cooperation in key areas such as neuromodulation and brain-computer interface, and promoting more technical exchanges and project implementation of semiconductor technology in the field of high-end medical care. This meeting laid a solid foundation for the future strategic cooperation between IntelliMicro and the world’s top high-tech and high-end medical enterprises, and Intellimciro will cooperate with more global technological healthcare giants to participate in global health governance at a deeper level and benefit mankind.